Skip to main content
. 2016 Apr 27;7:71. doi: 10.3389/fgene.2016.00071

Table 1.

Patient characteristics and demographics.

Variable Category Counts Percent
AVERAGE AGE OF DIAGNOSIS (RANGE) 47 (30–75)
BRCA mutation status Negative 69 81.2
Positive 16 18.8
Age of diagnosis (by group) ≤40 30 35.3
>40 55 64.7
BRCAPRO estimations (average) At age of DCIS diagnosis 0–97 15
Addition of 10 years to age of DCIS diagnosis 0–89.9 10
As No Cancer 0–35 2
Race White 72 84.7
African–American 3 3.5
Hispanic 5 5.9
Asian 5 5.9
Ashkenazi Jewish (AJ) Ancestry Unknown 1 1.2
No 77 90.6
Yes 7 8.2
FAMILY HISTORY CHARACTERISTICS
First degree relatives with BC 0 47 55.3
1 30 35.3
2 8 9.4
Second degree relatives with breast cancer 0 28 32.9
1 37 43.5
2 20 23.5
Total number of relatives with BC 0 9 10.6
1 15 17.7
2 20 23.5
3 21 24.7
4 20 23.5
First degree relatives with ovarian cancer 0 80 94.1
1 5 5.9
Second degree relatives with ovarian cancer 0 77 90.6
1 6 7.1
2 2 2.4
Total number of relatives with ovarian cancer 0 68 80.0
≥1 17 20.0
Bilateral salphingo oophorectomy (BSO) Unknown 3 3.5
No 64 75.3
Yes 18 21.2
TUMOR CHARACTERISTICS
Nuclear grade I 6 7.1
II 35 41.2
III 34 40.0
Unknown 10 11.8
Estrogen receptor (ER) Negative 11 12.9
Positive 59 69.4
Unknown 15 17.7
Progesteron receptor (PR) Negative 18 21.2
Positive 51 60.0
Unknown 16 18.8